Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients

• Κύριοι συγγραφείς: Zufit Hexner-Erlichman (Συγγραφέας), Maria Veiga- (Συγγραφέας), Yoav Zehavi (Συγγραφέας), Zahava Vadasz (Συγγραφέας), Adi D. Sabag (Συγγραφέας), Sameh Tatour (Συγγραφέας), Ronen Spiegel (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2022-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

BackgroundGlycogen storage disease type 1b (GSD1b) is an ultra-rare autosomal recessive disorder, caused by mutations in SLC37A4 gene. Affected patients present with episodes of fasting hypoglycemia and lactic acidosis, hepatomegaly, growth retardation, hyperlipidemia and renal impairment. In additi...